A partnership between Virginia Western Community College, Roanoke City, and the Roanoke-Blacksburg Technology Council.
Mark founded healthEscores with the intent of creating Software-as-a-Service products that could efficiently capture patient experience data in small, independent health care practices. By minimizing the human capital required to collect and analyze patient experience data. healthEscores hoped to streamline strategic planning and operational decision-making, ultimately reducing the administrative burden of managing these practices. Mark will continue consulting in health care and plans to earn his MHA/MBA starting fall 2019.
Brockworks, a virtual construction company, is working nationwide with custom builders, providing detailed 3D models, constructability reviews, and model-based quantity takeoffs, long before construction begins. Brockworks not only provides the detailed virtual-reality experience but also identifies structural problems, as well as other potential issues, saving builders time and money.
Flewid Capital is using traditional and blockchain technology to create a global payment platform that will initially be marketed to immigrants, including international students and some short-term travelers from South and Southeast Asia and Sub-Saharan Africa. Further, the default trading unit has value based on a unique algorithm that mitigates the risk of sudden loss or gain in value due to shifts in the economy or demand.
BEAM Diagnostics, Inc. is founded on the concept that self-control failure underlies a wide range of negative health, safety, and financial behaviors. As the first of many applications, BEAM has chosen to focus on alcohol misuse by developing BEACON, an app that generates a patient’s reinforcer pathology score (RPscore) as a quantitative measure of alcohol misuse severity to a clinician in under 4 minutes. BEACON addresses many limitations present in current substance-use screening by saving time, reducing stigmatization, and promoting preventative screening for a debilitating disease.
Chorda Pharma is a pharmaceutical company specializing in the development of novel analgesic medications. Chorda Pharma is currently working with a team of experts to launch its first product into the U.S. over-the-counter pain management pharmaceutical market, with a topical medication designed for the treatment of pain due to osteoarthritis.
Leone BioVentures, LLC is developing a bio-pesticide that will have a worldwide market. The bio-pesticide agent has been proven to be effective against a wide variety of crop diseases in previous field and greenhouse trials. Josh James (COO), a Bioengineering graduate from Virginia Tech, is developing feasible methods to scale up production of the bio-pesticide product.
Skyphos is dedicated to improving translation of point-of-care medical diagnostics and developing next-gen healthcare platforms. Our specialized 3D printing (3DP) finds high utility among groups working in micro-electro-mechanical systems (MEMS) and lab-on-a-chip (LOAC). Skyphos fabricates on-device components/features ranging in size from single-digit microns to several inches within the same print – for the first time enabling prototyping on-demand and outside of a clean-room. The machine and the processes it utilizes were designed from the ground up to overcome limitations imposed by lithography. Our technology offers prototyping in minutes vs. months, true 3D structures, and incredibly rich textures-enhancing the interrogation area. This permits fabrication of devices previously not possible, radically altering the consumption and fabrication models for MEMS and LOAC.